raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:159

Carnitine-acylcarnitine translocase deficiency

Synonyms: CACT deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

Carnitine-acylcarnitine translocase (CACT) deficiency is a life-threatening, inherited disorder of fatty acid oxidation which usually presents in the neonatal period with severe hypoketotic hypoglycemia, hyperammonemia, cardiomyopathy and/or arrhythmia, hepatic dysfunction, skeletal muscle weakness, and encephalopathy.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCarnitine-acylcarnitine translocase deficiencyCACT deficiency
frDéficit en carnitine-acylcarnitine translocaseDéficit en CACT
deCarnitin-Acylcarnitin-Translokase-MangelCACT-Mangel
esDeficiencia de carnitina-acilcarnitina translocasaDeficiencia de CACT
itDeficit di carnitina-acilcarnitina traslocasiDeficit di CACT
nlDeficiëntie van carnitine-acylcarnitine translocaseCACT-deficiëntie
ptDeficiência de carnitina-acilcarnitina translocase
plNiedobór translokazy karnityno-acylokarnitynowejNiedobór CACT
csDeficit karnitinacylkarnitintranslokázyCACT deficit
ukДефіцит карнітин-ацилкарнітинової транслоказиДефіцит CACT
zh肉毒碱-酰肉碱移位酶缺乏症CACT缺乏症
trKarnitin-açilkarnitin translokaz eksikliğiCACT eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM212138Evalidated
ICD-10E71.3NTBTattributedvalidated
ICD-115C52.00NTBTindexvalidated
MONDO0008918Evalidated
MeSHC562812Evalidated
UMLSC0342791Evalidated
GARD1123Evalidated
MedDRA10078729Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
SLC25A20Disease-causing germline mutation(s) inAssessedHGNC:1421ENSG000001785376136983p21.31solute carrier family 25 member 20
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families60 casesWorldwideCase(s)Validated24088670[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

30 annotations · validated 2017-08-23
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0011675Arrhythmia
HP:0001638Cardiomyopathy
HP:0003234Decreased circulating carnitine concentration
HP:0003215Dicarboxylic aciduria
HP:0002910Elevated circulating hepatic transaminase concentration
HP:0008331Elevated creatine kinase after exercise
HP:0045045Elevated plasma acylcarnitine levels
HP:0001298Encephalopathy
HP:0003162Fasting hypoglycemia
HP:0001263Global developmental delay
HP:0002240Hepatomegaly
HP:0001987Hyperammonemia
HP:0001985Hypoketotic hypoglycemia
HP:0002615Hypotension
HP:0000737Irritability
HP:0001254Lethargy
HP:0001324Muscle weakness
HP:0002093Respiratory insufficiency
HP:0003201Rhabdomyolysis
HP:0004756Ventricular tachycardia
Occasional (29-5%)
HP:0001259Coma
HP:0000961Cyanosis
HP:0001399Hepatic failure
HP:0002045Hypothermia
HP:0000252Microcephaly
HP:0000639Nystagmus
HP:0100520Oliguria
HP:0100602Preeclampsia
HP:0001250Seizure
HP:0002882Sudden episodic apnea

Run the differential on the 12 obligate / very frequent terms

Annotation source: 7350426[PMID]_1598097[PMID]_8450053[PMID]_10577999[PMID]_17578469[PMID]_24088670[PMID]

7

Sources for this card